Skip to main content
. 2020 Apr 8;12(4):1021. doi: 10.3390/nu12041021

Figure 1.

Figure 1

Factors that have an impact on bone metabolism in gastroenteropancreatic–neuroendocrine tumors (GEP–NETs) patients in addition to bone metastases. The arrows indicate the interaction among the different factors.